Cramer says look to these 4 stocks to go with your high-flying tech names
CNBC's Jim Cramer said Thursday investors should look beyond the market's hottest trades and start hunting for opportunities in areas ...
Tag: Health care industry
How Trump’s psychedelics executive order could unlock stalled cannabis reform
Advocates attend a news conference about the "impact of incarcerating those charged with marijuana-related offenses," and policy reform ideas, outside ...
Trump nominates Erica Schwartz as CDC director amid turmoil around leadership, vaccine policy
Rear Admiral Erica G. Schwartz.U.S. Department of Health and Human ServicesPresident Donald Trump on Thursday nominated Erica Schwartz to serve ...
Novo Nordisk’s explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight loss treatment
After years of trying to lose weight "the right way," Jane Zuckerman realized that "putting in the work just wasn't ...
Trump administration finalizes better-than-feared Medicare Advantage payment rate in boost to health insurers
Administrator for the Centers for Medicare & Medicaid Services Mehmet Oz speaks during an event sponsored by the Action for ...
Trump administration sets up to 100% tariffs on some imported drugs, with many companies exempt
The Trump administration on Thursday imposed new tariffs on branded drugs from pharmaceutical companies that have not struck deals with ...
Eli Lilly reaches $2.75 billion deal with Insilico to bring AI-developed drugs to the global market
A drone view shows the Eli Lilly logo on the company’s office in San Diego, California, Nov. 21, 2025.Mike Blake ...
The price of menstrual products is skyrocketing from inflation, tariffs
Always products are displayed on a shelf in a supermarket in Sarajevo, Bosnia and Herzegovina October 29, 2024. Dado Ruvic | ...
GLP-1 drugs are changing how Americans eat. Food companies are racing to catch up
A mini burger, mini fries and mini beer, Clinton Hall's "Teeny Weeny Mini Meal", is pictured next to a regular-sized ...
Eli Lilly’s next-generation obesity drug retatrutide clears first late-stage diabetes trial
Eli Lilly on Thursday said its next-generation obesity drug retatrutide cleared its first late-stage trial on Type 2 diabetes patients, ...
